摘要
Bacteria use tight-binding, ferric-specific chelators called siderophores to acquire iron from the environment and from the host during infection; animals use proteins such as transferrin and ferritin to transport and store iron. Recently, candidate compounds that could serve endogenously as mammalian siderophore equivalents have been identified and characterized through associations with siderocalin, the only mammalian siderophore-binding protein currently known. Siderocalin, an antibacterial protein, acts by sequestering iron away from infecting bacteria as siderophore complexes. Candidate endogenous siderophores include compounds that only effectively transport iron as ternary complexes with siderocalin, explaining pleiotropic activities in normal cellular processes and specific disease states. Bacteria use tight-binding, ferric-specific chelators called siderophores to acquire iron from the environment and from the host during infection; animals use proteins such as transferrin and ferritin to transport and store iron. Recently, candidate compounds that could serve endogenously as mammalian siderophore equivalents have been identified and characterized through associations with siderocalin, the only mammalian siderophore-binding protein currently known. Siderocalin, an antibacterial protein, acts by sequestering iron away from infecting bacteria as siderophore complexes. Candidate endogenous siderophores include compounds that only effectively transport iron as ternary complexes with siderocalin, explaining pleiotropic activities in normal cellular processes and specific disease states. Iron is required by virtually all living things (1Nadadur S.S. Srirama K. Mudipalli A. Iron transport and homeostasis mechanisms: their role in health and disease.Indian J. Med. Res. 2008; 128: 533-544PubMed Google Scholar). The biological versatility of iron, which participates in a variety of chemical reactions and as a structural component in proteins, is partly due to its tunable redox states. Despite its abundance in the biosphere, free ferric iron (Fe(III)), the form of iron present under aerobic conditions, is relatively inaccessible to biological systems, as it forms hydroxides, which are insoluble at physiological pH, limiting Fe(III) concentrations to ∼10−18 m in the absence of solubilizing agents (2Raymond K.N. Carrano C.J. Coordination chemistry and microbial iron transport.Acc. Chem. Res. 1979; 12: 183-190Crossref Scopus (319) Google Scholar, 3Theil E.C. Goss D.J. Living with iron (and oxygen): questions and answers about iron homeostasis.Chem. Rev. 2009; 109: 4568-4579Crossref PubMed Scopus (211) Google Scholar). Within the body, where the majority of iron is present as heme, free iron concentrations are maintained at even lower levels, partly because free iron is cytotoxic through its facility to catalyze Fenton chemistry, reacting with oxidants to generate damaging hydroxyl radical species (4Wessling-Resnick M. Biochemistry of iron uptake.Crit. Rev. Biochem. Mol. Biol. 1999; 34: 285-314Crossref PubMed Scopus (60) Google Scholar, 5Valerio L.G. Mammalian iron metabolism.Toxicol. Mech. Methods. 2007; 17: 497-517Crossref PubMed Scopus (33) Google Scholar, 6Lieu P.T. Heiskala M. Peterson P.A. Yang Y. The roles of iron in health and disease.Mol. Aspects Med. 2001; 22: 1-87Crossref PubMed Scopus (602) Google Scholar). Consequently, animals have evolved highly specialized networks of proteins that maintain normal iron homeostasis and prevent deleterious side reactions during storage (e.g. ferritin) and transport (e.g. transferrin (Tf) 2The abbreviations used are: TftransferrinTfR1Tf receptor 1LIPlabile iron poolEntenterobactinDHBAdihydroxybenzoateCatcatechol.) of iron; the translation of these proteins and their receptors is regulated in response to intracellular iron levels (7Muckenthaler M.U. Galy B. Hentze M.W. Systemic iron homeostasis and the iron-responsive element/iron regulatory protein (IRE/IRP) regulatory network.Annu. Rev. Nutr. 2008; 28: 197-213Crossref PubMed Scopus (520) Google Scholar, 8Recalcati S. Minotti G. Cairo G. Iron regulatory proteins: from molecular mechanisms to drug development.Antioxid. Redox Signal. 2010; 13: 1593-1616Crossref PubMed Scopus (94) Google Scholar, 9Hentze M.W. Muckenthaler M.U. Galy B. Camaschella C. Two to tango: regulation of mammalian iron metabolism.Cell. 2010; 142: 24-38Abstract Full Text Full Text PDF PubMed Scopus (1533) Google Scholar). transferrin Tf receptor 1 labile iron pool enterobactin dihydroxybenzoate catechol. Whereas Fe(III) predominates in aerobic environments, ferrous iron (Fe(II)) is more bioavailable (soluble and transportable) and predominates under the reducing conditions inside cells, constraints that combine to require a constant cycling between ferric and ferrous forms during import and export in vivo, with many organisms coupling enzymatic reduction of iron with transport (10Kosman D.J. Redox cycling in iron uptake, efflux, and trafficking.J. Biol. Chem. 2010; 285: 26729-26735Abstract Full Text Full Text PDF PubMed Scopus (85) Google Scholar, 11Pierre J.L. Fontecave M. Crichton R.R. Chemistry for an essential biological process: the reduction of ferric iron.Biometals. 2002; 15: 341-346Crossref PubMed Scopus (130) Google Scholar, 12Weber K.A. Achenbach L.A. Coates J.D. Microorganisms pumping iron: anaerobic microbial iron oxidation and reduction.Nat. Rev. Microbiol. 2006; 4: 752-764Crossref PubMed Scopus (1295) Google Scholar). In plasma, iron is found almost exclusively bound to Tf, which is present at concentrations as high as 50 μm (13Anderson G.J. Vulpe C.D. Mammalian iron transport.Cell. Mol. Life Sci. 2009; 66: 3241-3261Crossref PubMed Scopus (237) Google Scholar) and is normally 30–40% iron-saturated (14Ponka P. Beaumont C. Richardson D.R. Function and regulation of transferrin and ferritin.Semin. Hematol. 1998; 35: 35-54PubMed Google Scholar); consequently, plasma concentrations of free Fe(III) average ∼10−24 m (15Otto B.R. Verweij-van Vught A.M. MacLaren D.M. Transferrins and heme compounds as iron sources for pathogenic bacteria.Crit. Rev. Microbiol. 1992; 18: 217-233Crossref PubMed Scopus (334) Google Scholar). Tf binds two atoms of Fe(III) with extremely high affinity (KD = 10−23 m−1) (16Aisen P. Leibman A. Zweier J. Stoichiometric and site characteristics of the binding of iron to human transferrin.J. Biol. Chem. 1978; 253: 1930-1937Abstract Full Text PDF PubMed Google Scholar) and delivers bound iron to cells through a specific cell-surface Tf receptor (TfR1) (17Leibman A. Aisen P. Transferrin receptor of the rabbit reticulocyte.Biochemistry. 1977; 16: 1268-1272Crossref PubMed Scopus (49) Google Scholar, 18Cheng Y. Zak O. Aisen P. Harrison S.C. Walz T. Structure of the human transferrin receptor-transferrin complex.Cell. 2004; 116: 565-576Abstract Full Text Full Text PDF PubMed Scopus (420) Google Scholar). The Tf-TfR1 complex is endocytosed and recycled through low pH endosomes, where iron is released from Tf and concomitantly reduced. Released Fe(II) is transported into the cytoplasm by DMT1 (divalent metal transporter 1), where it becomes available for utilization or storage (19Andrews N.C. The iron transporter DMT1.Int. J. Biochem. Cell Biol. 1999; 31: 991-994Crossref PubMed Scopus (206) Google Scholar). Under normal physiological conditions, excess iron is stored within ferritin, a spherical cage consisting of 24 protein protomers arranged with cubic (432) symmetry as a hydrous ferric oxide core (20Chasteen N.D. Harrison P.M. Mineralization in ferritin: an efficient means of iron storage.J. Struct. Biol. 1999; 126: 182-194Crossref PubMed Scopus (694) Google Scholar). The heavy chain of ferritin is responsible for oxidizing cytoplasmic ferrous iron to facilitate its storage within the ferritin cage (21Treffry A. Hirzmann J. Yewdall S.J. Harrison P.M. Mechanism of catalysis of Fe(II) oxidation by ferritin H chains.FEBS Lett. 1992; 302: 108-112Crossref PubMed Scopus (79) Google Scholar). The continuous demand of iron for cellular processes requires a constant flux from the extracellular milieu to the cytoplasm; however, how iron is transported to sites of storage and utilization within the cell is still poorly understood. Because of its reactivity, transitory iron is presumably bound to and solubilized by small molecule (<1 kDa) ligands, making up what is known as the chelatable or labile iron pool (LIP), proposed to be a transitory source or sink of extracellular and intracellular Fe(III) and Fe(II), although its exact composition remains unclear (22Kakhlon O. Cabantchik Z.I. The labile iron pool: characterization, measurement, and participation in cellular processes.Free Radic. Biol. Med. 2002; 33: 1037-1046Crossref PubMed Scopus (649) Google Scholar, 23Breuer W. Shvartsman M. Cabantchik Z.I. Intracellular labile iron.Int. J. Biochem. Cell Biol. 2008; 40: 350-354Crossref PubMed Scopus (149) Google Scholar, 24Jacobs A. Low molecular weight intracellular iron transport compounds.Blood. 1977; 50: 433-439Crossref PubMed Google Scholar). Characterization of the LIP has been difficult due to its transient nature and the complexity of chemically identifying specific iron complexes within the cell or following cell disruption (22Kakhlon O. Cabantchik Z.I. The labile iron pool: characterization, measurement, and participation in cellular processes.Free Radic. Biol. Med. 2002; 33: 1037-1046Crossref PubMed Scopus (649) Google Scholar). Proposed ferric ligands include ionic compounds such as citrate and phosphate, polypeptides, and phospholipids, but the physiological relevance of these compounds and their roles in iron homeostasis have not been determined (25Kruszewski M. Labile iron pool: the main determinant of cellular response to oxidative stress.Mutat. Res. 2003; 531: 81-92Crossref PubMed Scopus (413) Google Scholar). Normal iron homeostasis can be altered in a variety of disease states, including infections and cancer, where the tightly controlled levels of available iron in the body are further reduced to slow or stop the growth of pathogens and tumors through depletion of this necessary resource. In patients with microbial infections, iron supplementation often significantly worsens their condition, demonstrating the importance of the tight control of iron in disease (26Weinberg E.D. Iron withholding: a defense against infection and neoplasia.Physiol. Rev. 1984; 64: 65-102Crossref PubMed Scopus (641) Google Scholar, 27Jurado R.L. Iron, infections, and anemia of inflammation.Clin. Infect. Dis. 1997; 25: 888-895Crossref PubMed Scopus (331) Google Scholar, 28Cherayil B.J. The role of iron in the immune response to bacterial infection.Immunol. Res. 2011; 50: 1-9Crossref PubMed Scopus (129) Google Scholar). An example of a component of this defense is the iron-binding protein lactoferrin (first discovered in milk), which is a bacteriostatic agent that is released from neutrophil granules at sites of inflammation, inhibiting the growth of infecting pathogens by directly sequestering iron (13Anderson G.J. Vulpe C.D. Mammalian iron transport.Cell. Mol. Life Sci. 2009; 66: 3241-3261Crossref PubMed Scopus (237) Google Scholar, 29Andrews N.C. Forging a field: the golden age of iron biology.Blood. 2008; 112: 219-230Crossref PubMed Scopus (496) Google Scholar, 30Wang L. Cherayil B.J. Ironing out the wrinkles in host defense: interactions between iron homeostasis and innate immunity.J. Innate Immun. 2009; 1: 455-464Crossref PubMed Scopus (47) Google Scholar). To acquire iron in the face of the tight controls imposed through normal homeostasis and by antibacterial defenses, colonizing or infecting microbes use several approaches: dispensing with any need for iron (a rare example is Borrelia burgdorferi, the causative agent of Lyme disease (31Posey J.E. Gherardini F.C. Lack of a role for iron in the Lyme disease pathogen.Science. 2000; 288: 1651-1653Crossref PubMed Scopus (404) Google Scholar)); acquiring iron directly from heme, Tf, or lactoferrin (32Cornelissen C.N. Sparling P.F. Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens.Mol. Microbiol. 1994; 14: 843-850Crossref PubMed Scopus (207) Google Scholar, 33Cornelissen C.N. Transferrin iron uptake by Gram-negative bacteria.Front. Biosci. 2003; 8: d836-d847Crossref PubMed Scopus (61) Google Scholar); or acquiring iron through ferric-specific chemical chelators called siderophores (34Miethke M. Marahiel M.A. Siderophore-based iron acquisition and pathogen control.Microbiol. Mol. Biol. Rev. 2007; 71: 413-451Crossref PubMed Scopus (1184) Google Scholar, 35Wandersman C. Delepelaire P. Bacterial iron sources: from siderophores to hemophores.Annu. Rev. Microbiol. 2004; 58: 611-647Crossref PubMed Scopus (770) Google Scholar). Siderophores are secreted, low molecular mass (<1 kDa) compounds with remarkable iron complex formation constants: pFe7.4 is 23.5 for the siderophore aerobactin and 35.5 for the siderophore enterobactin (Ent; also enterochelin). Siderophore iron affinities are sufficient to solubilize iron exogenously in marine and terrestrial environments and to strip iron from direct iron-binding proteins endogenously, such as lactoferrin and Tf (36Neilands J.B. Microbial iron compounds.Annu. Rev. Biochem. 1981; 50: 715-731Crossref PubMed Scopus (868) Google Scholar, 37Garibaldi J.A. Neilands J.B. Formation of iron-binding compounds by microorganisms.Nature. 1956; 177: 526-527Crossref PubMed Scopus (38) Google Scholar, 38Ford S. Cooper R.A. Evans R.W. Hider R.C. Williams P.H. Domain preference in iron removal from human transferrin by the bacterial siderophores aerobactin and enterochelin.Eur. J. Biochem. 1988; 178: 477-481Crossref PubMed Scopus (30) Google Scholar). Siderophores form kinetically stable complexes with iron that are entropically favored by encapsulating ferric ions and displacing hexacoordinated water molecules; siderophores are often synthesized from amino acid precursors through non-ribosomal peptide synthesis (34Miethke M. Marahiel M.A. Siderophore-based iron acquisition and pathogen control.Microbiol. Mol. Biol. Rev. 2007; 71: 413-451Crossref PubMed Scopus (1184) Google Scholar). Siderophore chelating functionalities include catecholates, hydroxamates, and α-hydroxycarboxylates (although other chemistries are known) that contain hard base oxygen atoms to satisfy the preferred hexadentate coordination of ferric iron (Fig. 1). Siderophores display only weak affinities for Fe(II), allowing microbes to couple enzymatic reduction, leading to iron release, with siderophore import (39Neilands J.B. Siderophores: structure and function of microbial iron transport compounds.J. Biol. Chem. 1995; 270: 26723-26726Abstract Full Text Full Text PDF PubMed Scopus (1254) Google Scholar). Ent, a triscatecholate siderophore secreted by many enteric bacteria, displays essentially ideal hexadentate iron coordination, making it among the most potent siderophores known (40Loomis L.D. Raymond K.N. Solution equilibria of enterobactin and metal-enterobactin complexes.Inorg. Chem. 1991; 30: 906-911Crossref Scopus (278) Google Scholar, 41Stack T.D. Karpishin T.B. Raymond K.N. Structural and spectroscopic characterization of chiral ferric tris-catecholamides: unraveling the design of enterobactin.J. Am. Chem. Soc. 1992; 114: 1512-1514Crossref Scopus (67) Google Scholar). Ent consists of three 2,3-dihydroxybenzoate (2,3-DHBA) groups, a bidentate iron chelator on its own, organized into a single hexadentate compound through amide linkages to a backbone consisting of three serine residues coupled through lactone linkages (42Raymond K.N. Dertz E.A. Kim S.S. Enterobactin: an archetype for microbial iron transport.Proc. Natl. Acad. Sci. U.S.A. 2003; 100: 3584-3588Crossref PubMed Scopus (685) Google Scholar). Siderophores that do not contain six ligating groups, such as bidentate and tetradentate compounds, fully satisfy iron coordination by forming higher order iron complexes, as is seen with bidentate 2,3-DHBA (forming FeL3 complexes) and tetradentate siderophores like alcaligin and amonabactin, which form Fe2L3 complexes with Fe(III) (43Klumpp C. Burger A. Mislin G.L. Abdallah M.A. From a total synthesis of cepabactin and its 3:1 ferric complex to the isolation of a 1:1:1 mixed complex between iron (III), cepabactin, and pyochelin.Bioorg. Med. Chem. Lett. 2005; 15: 1721-1724Crossref PubMed Scopus (28) Google Scholar, 44Hou Z. Raymond K.N. O'Sullivan B. Esker T.W. Nishio T. A preorganized siderophore: thermodynamic and structural characterization of alcaligin and bisucaberin, microbial macrocyclic dihydroxamate-chelating agents.Inorg. Chem. 1998; 37: 6630-6637Crossref PubMed Scopus (51) Google Scholar, 45Barghouthi S. Young R. Olson M.O. Arceneaux J.E. Clem L.W. Byers B.R. Amonabactin, a novel tryptophan- or phenylalanine-containing phenolate siderophore in Aeromonas hydrophila.J. Bacteriol. 1989; 171: 1811-1816Crossref PubMed Google Scholar). Many siderophores combine multiple ligation chemistries, such as carboxymycobactin, which contains phenolate-oxazoline and hydroxamate groups, and citrate-based siderophores like aerobactin and schizokinen, which utilize α-hydroxycarboxylate and hydroxamate-chelating groups (Fig. 1) (36Neilands J.B. Microbial iron compounds.Annu. Rev. Biochem. 1981; 50: 715-731Crossref PubMed Scopus (868) Google Scholar, 46Ratledge C. Ewing M. The occurrence of carboxymycobactin, the siderophore of pathogenic mycobacteria, as a second extracellular siderophore in Mycobacterium smegmatis.Microbiology. 1996; 142: 2207-2212Crossref PubMed Scopus (76) Google Scholar, 47Warner P.J. Williams P.H. Bindereif A. Neilands J.B. ColV plasmid-specific aerobactin synthesis by invasive strains of Escherichia coli.Infect. Immun. 1981; 33: 540-545Crossref PubMed Google Scholar, 48Mullis K.B. Pollack J.R. Neilands J.B. Structure of schizokinen, an iron transport compound from Bacillus megaterium.Biochemistry. 1971; 10: 4894-4898Crossref PubMed Scopus (79) Google Scholar). Virulence is often associated with the utilization of distinct or multiple siderophores with varying chelation chemistries and backbone structures, as is seen in pathogenic Escherichia coli, which secretes both Ent and aerobactin, although the explanation for this association was not initially apparent (47Warner P.J. Williams P.H. Bindereif A. Neilands J.B. ColV plasmid-specific aerobactin synthesis by invasive strains of Escherichia coli.Infect. Immun. 1981; 33: 540-545Crossref PubMed Google Scholar, 49Carniel E. The Yersinia high pathogenicity island: an iron uptake island.Microbes Infect. 2001; 3: 561-569Crossref PubMed Scopus (166) Google Scholar, 50Klee S.R. Nassif X. Kusecek B. Merker P. Beretti J.L. Achtman M. Tinsley C.R. Molecular and biological analysis of eight genetic islands that distinguish Neisseria meningitidis from the closely related pathogen Neisseria gonorrhoeae.Infect. Immun. 2000; 68: 2082-2095Crossref PubMed Scopus (87) Google Scholar, 51Vokes S.A. Reeves S.A. Torres A.G. Payne S.M. The aerobactin iron transport system genes in Shigella flexneri are present within a pathogenicity island.Mol. Microbiol. 1999; 33: 63-73Crossref PubMed Scopus (119) Google Scholar). In response to the use of siderophores by bacteria to steal iron from host iron-sequestering proteins, the armamentarium of the immune system includes proteins that sequester ferric siderophore complexes away from bacterial siderophore receptors (52Clifton M.C. Corrent C. Strong R.K. Siderocalins: siderophore-binding proteins of the innate immune system.Biometals. 2009; 22: 557-564Crossref PubMed Scopus (59) Google Scholar). All of the known or hypothesized members of this functional group of proteins belong to the lipocalin family of binding proteins and so are known as “siderocalins” for “siderophore-binding lipocalins.” The lipocalin family of binding proteins displays a conserved eight-stranded β-barrel fold, which encompasses a highly sculpted binding site known as a calyx. Siderocalins include the mammalian lipocalins Lcn1 (lipocalin 1; also tear lipocalin or von Ebner's gland protein (53Fluckinger M. Haas H. Merschak P. Glasgow B.J. Redl B. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores.Antimicrob. Agents Chemother. 2004; 48: 3367-3372Crossref PubMed Scopus (169) Google Scholar)) and the archetype of the family, Scn (also know as NGAL (neutrophil gelatinase-associated lipocalin), Lcn2, or 24p3 (54Goetz D.H. Holmes M.A. Borregaard N. Bluhm M.E. Raymond K.N. Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition.Mol. Cell. 2002; 10: 1033-1043Abstract Full Text Full Text PDF PubMed Scopus (1076) Google Scholar)), and the close pair of avian orthologs Q83 and Ex-FABP (55Coudevylle N. Geist L. Hötzinger M. Hartl M. Kontaxis G. Bister K. Konrat R. The v-myc-induced Q83 lipocalin is a siderocalin.J. Biol. Chem. 2010; 285: 41646-41652Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar, 56Holmes M.A. Paulsene W. Jide X. Ratledge C. Strong R.K. Siderocalin (Lcn2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration.Structure. 2005; 13: 29-41Abstract Full Text Full Text PDF PubMed Scopus (212) Google Scholar). Siderocalins often bind siderophores with subnanomolar affinities (54Goetz D.H. Holmes M.A. Borregaard N. Bluhm M.E. Raymond K.N. Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition.Mol. Cell. 2002; 10: 1033-1043Abstract Full Text Full Text PDF PubMed Scopus (1076) Google Scholar, 55Coudevylle N. Geist L. Hötzinger M. Hartl M. Kontaxis G. Bister K. Konrat R. The v-myc-induced Q83 lipocalin is a siderocalin.J. Biol. Chem. 2010; 285: 41646-41652Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar, 56Holmes M.A. Paulsene W. Jide X. Ratledge C. Strong R.K. Siderocalin (Lcn2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration.Structure. 2005; 13: 29-41Abstract Full Text Full Text PDF PubMed Scopus (212) Google Scholar, 57Hoette T.M. Abergel R.J. Xu J. Strong R.K. Raymond K.N. The role of electrostatics in siderophore recognition by the immunoprotein siderocalin.J. Am. Chem. Soc. 2008; 130: 17584-17592Crossref PubMed Scopus (46) Google Scholar, 58Abergel R.J. Moore E.G. Strong R.K. Raymond K.N. Microbial evasion of the immune system: structural modifications of enterobactin impair siderocalin recognition.J. Am. Chem. Soc. 2006; 128: 10998-10999Crossref PubMed Scopus (55) Google Scholar, 59Abergel R.J. Wilson M.K. Arceneaux J.E. Hoette T.M. Strong R.K. Byers B.R. Raymond K.N. Anthrax pathogen evades the mammalian immune system through stealth siderophore production.Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 18499-18503Crossref PubMed Scopus (161) Google Scholar, 60Abergel R.J. Clifton M.C. Pizarro J.C. Warner J.A. Shuh D.K. Strong R.K. Raymond K.N. The siderocalin/enterobactin interaction: a link between mammalian immunity and bacterial iron transport.J. Am. Chem. Soc. 2008; 130: 11524-11534Crossref PubMed Scopus (85) Google Scholar), using, in the cases of Scn and the avian siderocalins, calyces lined with positively charged lysine and arginine side chains to interact, through cation-π and Coulombic interactions, with negatively charged siderophores with aromatic catecholate groups. To broaden the range of this antibacterial defense, Scn, the best characterized member of the family, uses a highly polyspecific recognition mechanism to sequester both a wide range of related Ent-like siderophores and the chemically distinct carboxymycobactins (54Goetz D.H. Holmes M.A. Borregaard N. Bluhm M.E. Raymond K.N. Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition.Mol. Cell. 2002; 10: 1033-1043Abstract Full Text Full Text PDF PubMed Scopus (1076) Google Scholar, 55Coudevylle N. Geist L. Hötzinger M. Hartl M. Kontaxis G. Bister K. Konrat R. The v-myc-induced Q83 lipocalin is a siderocalin.J. Biol. Chem. 2010; 285: 41646-41652Abstract Full Text Full Text PDF PubMed Scopus (23) Google Scholar, 56Holmes M.A. Paulsene W. Jide X. Ratledge C. Strong R.K. Siderocalin (Lcn2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration.Structure. 2005; 13: 29-41Abstract Full Text Full Text PDF PubMed Scopus (212) Google Scholar, 57Hoette T.M. Abergel R.J. Xu J. Strong R.K. Raymond K.N. The role of electrostatics in siderophore recognition by the immunoprotein siderocalin.J. Am. Chem. Soc. 2008; 130: 17584-17592Crossref PubMed Scopus (46) Google Scholar, 58Abergel R.J. Moore E.G. Strong R.K. Raymond K.N. Microbial evasion of the immune system: structural modifications of enterobactin impair siderocalin recognition.J. Am. Chem. Soc. 2006; 128: 10998-10999Crossref PubMed Scopus (55) Google Scholar, 59Abergel R.J. Wilson M.K. Arceneaux J.E. Hoette T.M. Strong R.K. Byers B.R. Raymond K.N. Anthrax pathogen evades the mammalian immune system through stealth siderophore production.Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 18499-18503Crossref PubMed Scopus (161) Google Scholar, 60Abergel R.J. Clifton M.C. Pizarro J.C. Warner J.A. Shuh D.K. Strong R.K. Raymond K.N. The siderocalin/enterobactin interaction: a link between mammalian immunity and bacterial iron transport.J. Am. Chem. Soc. 2008; 130: 11524-11534Crossref PubMed Scopus (85) Google Scholar); Scn knock-out mice are significantly more susceptible to infections with bacteria that rely on these siderophores for iron acquisition in the absence of any other gross phenotype (61Berger T. Togawa A. Duncan G.S. Elia A.J. You-Ten A. Wakeham A. Fong H.E. Cheung C.C. Mak T.W. Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury.Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 1834-1839Crossref PubMed Scopus (371) Google Scholar, 62Flo T.H. Smith K.D. Sato S. Rodriguez D.J. Holmes M.A. Strong R.K. Akira S. Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron.Nature. 2004; 432: 917-921Crossref PubMed Scopus (1399) Google Scholar, 63Halaas O. Steigedal M. Haug M. Awuh J.A. Ryan L. Brech A. Sato S. Husebye H. Cangelosi G.A. Akira S. Strong R.K. Espevik T. Flo T.H. Intracellular Mycobacterium avium intersects transferrin in the Rab11+ recycling endocytic pathway and avoids lipocalin 2 trafficking to the lysosomal pathway.J. Infect. Dis. 2010; 201: 783-792Crossref PubMed Scopus (54) Google Scholar). Pathogenic bacteria have evolved responses to these defenses by using multiple siderophores that include examples that do not bind to Scn or by modifying siderophores in ways to block Scn binding, allowing iron to be acquired even in the presence of Scn and explaining much of the previously mysterious association of variant siderophores with virulence (54Goetz D.H. Holmes M.A. Borregaard N. Bluhm M.E. Raymond K.N. Strong R.K. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition.Mol. Cell. 2002; 10: 1033-1043Abstract Full Text Full Text PDF PubMed Scopus (1076) Google Scholar, 58Abergel R.J. Moore E.G. Strong R.K. Raymond K.N. Microbial evasion of the immune system: structural modifications of enterobactin impair siderocalin recognition.J. Am. Chem. Soc. 2006; 128: 10998-10999Crossref PubMed Scopus (55) Google Scholar, 59Abergel R.J. Wilson M.K. Arceneaux J.E. Hoette T.M. Strong R.K. Byers B.R. Raymond K.N. Anthrax pathogen evades the mammalian immune system through stealth siderophore production.Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 18499-18503Crossref PubMed Scopus (161) Google Scholar, 62Flo T.H. Smith K.D. Sato S. Rodriguez D.J. Holmes M.A. Strong R.K. Akira S. Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron.Nature. 2004; 432: 917-921Crossref PubMed Scopus (1399) Google Scholar, 64Fischbach M.A. Lin H. Zhou L. Yu Y. Abergel R.J. Liu D.R. Raymond K.N. Wanner B.L. Strong R.K. Walsh C.T. Aderem A. Smith K.D. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2.Proc. Natl. Acad. Sci. U.S.A. 2006; 103: 16502-16507Crossref PubMed Scopus (244) Google Scholar). For instance, Scn does not bind aerobactin, a weaker siderophore than Ent, the primary siderophore of many enteric bacteria, but aerobactin is associated with virulence by evading Scn sequestration. The idea that animals may utilize siderophores, much like bacteria, fungi, and even plants (monocots use phytosiderophores like mugineic acids to acquire iron (65Graham R.D. Stangoulis J.C. Trace element uptake and distribution in plants.J. Nutr. 2003; 133: 1502S-1505SCrossref PubMed Google Scholar)), has intrigued researchers for decades (66Fernandez-Pol J.A. Isolation and characterization of a siderophore-like growth factor from mutants of SV40-transformed cells adapted to picolinic acid.Cell. 1978; 14: 489-499Abstract Full Text PDF PubMed Scopus (61) Google Scholar, 67Jones R.L. Peterson C.M. Grady R.W. Cerami A. Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growth.J. Exp. Med. 1980; 151: 418-428Crossref PubMed Scopus (30) Google Scholar), but until recently, no candidate animal siderophores have been identified, characterized, and validated. Despite the fact that animals primarily acquire iron through diet and transport iron using specialized proteins, it is reasonable to speculate that animals may also take advantage of the beneficial properties of siderophores in managing the endogenous iron budget. Endogenous iron transport systems alternative to Tf have been hypothesized based on the phenotype of hypotransferrinemic mice and at